TechCrunch

FEBRUARY 23, 2022

Last year, round sizes for climate tech startups quadrupled, with more than 600 investments totaling over $40 billion. What is your climate tech investment thesis in H1 2022? We’re constructive around things like voluntary carbon markets. Which technologies are you paying attention to right now?

Technical Review 245

Technical Review Strategy .Net Biotech 245

N2Growth Blog

OCTOBER 23, 2023

With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. The life sciences industry is known for its unique challenges in recruiting and hiring.

Biotech 178

Biotech Strategy Artificial Inteligence Recruiting 178

Crunchbase News

JANUARY 7, 2025

Q4 push The higher total in 2024 was due to a big push in Q4 which saw the highest funding total since the downturn in Q3 2022. funding market raised a greater proportion of global funding, up from 48% in 2023. Large early-stage rounds went to data centers, renewable energy, AI, robotics and biotech. Of all U.S.

Artificial Intelligence 144

Artificial Intelligence Artificial Inteligence Report Technical Review 144

TechCrunch

NOVEMBER 21, 2022

Sure, due diligence matters in the investment process, but lying about your capabilities can undercut the founder-investor relationship — and in extreme cases, to the detriment of the larger, global startup market. Soon she was the CEO of a company with a $10 billion valuation, but it turned out that the technology didn’t work.

Technical Review 246

Technical Review Systems Review Healthcare Testing 246

TechCrunch

MAY 4, 2022

.” A more favorable regulatory and social landscape is helping psychedelic startups gain a foothold, but they still have to walk a tightrope that’s susceptible to the vagaries of market sentiment. But as public market sentiment fluctuates, specialized VCs seem more likely to stick around for the whole trip. Ready for the trip?

Marketing 235

Marketing Technical Review Biotech Weak Development Team 235

TechCrunch

JANUARY 16, 2021

Now tech companies across industries are poised for an even better year, according to more than a dozen investors we talked to in the country. Other investors felt that a broader range of industries, like fintech and biotech, would eventually produce the biggest companies in the country. Oh, and one more thing.

Technical Review 354

Technical Review Software Review Trends Systems Review 354

TechCrunch

JULY 26, 2021

The whole human proteome may be free to browse thanks to DeepMind , but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. At first Glyphic would be processing samples sent to them, but ultimately their tech could live in other labs as their competitors do now.

Biotech 249

Biotech Off-The-Shelf Chemicals Hardware 249

TechCrunch

AUGUST 18, 2022

The hearing loss market has long been dominated by a handful of legacy players with little incentive to innovate due to outdated regulations and social stigma. Food and Drug Administration could revolutionize the market by driving competition, giving startups a greater chance at success in this sector.

Technical Review 240

Technical Review Innovation Technology Systems Review 240

TechCrunch

AUGUST 18, 2023

We featured generative AI companies five years before the popular investors took notice and climate tech 2.0 We’re seeing input/output startups that want to rewrite the rules of recycling and purification with new tech. It’s deep tech but actionable. Silver tech – Life expectancy is on the rise and the U.S.

Biotech 221

Biotech Technical Review Fintech Trends 221

TechCrunch

MARCH 17, 2023

Zero-based budgeting: A proven framework for extending runway 5 strategies for biotech startups to outlast a market downturn Image Credits: Getty Images Spinning up a biotech company is a massive undertaking. “We don’t see that commitment from other banks.”

Budget 230

Budget Biotech Artificial Inteligence Banking 230

TechCrunch

OCTOBER 28, 2022

The biotech didn’t specify what roles and departments got trimmed. The Washington- and Lagos-based genomics startup has been considered the showpiece of Africa’s fledging biotech space since it got into Y Combinator in 2019. Yet, 2022 will be a year to forget for the biotech startup.

Biotech 229

Biotech Part-Time VPE Fractional VPE Pharmaceuticals 229

TechCrunch

NOVEMBER 7, 2023

French health tech brand Withings has been around the block and some. It was also an early mover in smart scales and is continuing to push the envelope here — with Body Scan, its current flagship scale (or “connected health station” as its marketing […] © 2023 TechCrunch.

Technical Review 235

Technical Review Marketing Biotech Hardware 235

TechCrunch

SEPTEMBER 14, 2021

Due to its safer formula, Howler can be used as the last spray in the program, and its differentiator is a shorter re-entry period — farmers can spray in the morning and be able to go back out in the field in the afternoon. Other fungicides on the market today require seven days before re-entry and pre-harvest, Uknes explained.

Technical Review 235

Technical Review Technology Chemicals Pharmaceuticals 235

TechCrunch

AUGUST 2, 2021

“We added fermentation/biotech technologies to enhance taste and texture,” wrote CEO and co-founder Christoph Jenny in an email to TechCrunch. The company plans to enter several new markets over Q3 and Q4, but the U.S. is still a question mark due to COVID-19 restrictions on travel.

Biotech 255

Biotech Technical Review Travel Course 255

TechCrunch

APRIL 3, 2023

“We seek out exceptional founding teams whose business plan is centered on the strategic utilization of technology to gain a competitive advantage. The technology sector has faced some short- to mid-term pressure globally due to recent market adjustments. We don’t limit ourselves to any specific sector,” Kazah said.

Technical Review 236

Technical Review Biotech Blockchain Fintech 236

TechCrunch

JUNE 9, 2021

According to research, 85% of African SMBs have zero access to financing, and e ach day, African SMBs have billions locked up in receivables due to long payment cycles. ” All the companies from Y Combinator’s W20 Demo Day, Part IV: Healthcare, Biotech, Fintech and Nonprofits. Ghansah is a serial entrepreneur.

Banking 348

Banking Technical Review Fintech Media 348

TechCrunch

JULY 19, 2022

Go on, then, here’s a few more stories (and some delightfully weird music by Cosmo Sheldrake to go with it): Ramp ramps rev growth : Mary Ann reports that Ramp reports accelerating revenue growth , showing that fintech companies with good product-market fit still have plenty of growth in them. Can Medicare save the insurtech market?

Airlines 246

Airlines Technical Review Fintech Blockchain 246

TechCrunch

OCTOBER 6, 2022

He believes that the tech ecosystem has matured quite a lot in France over the past ten years. France could become a leading market when it comes to sustainability-focused and impact startups due to local and European regulation, innovation and talent looking for opportunities in this ecosystem.

Sustainability 188

Sustainability Programming Technical Review Biotech 188

TechCrunch

JANUARY 31, 2023

“InstaDeep happened to be quite different from other companies in our pipeline as they were actually into deep tech versus applying technology to a certain sector, where basically, you become an operator in that sector. And it was also interesting, especially in Africa, where such companies are quite rare.

Technical Review 248

Technical Review Biotech Systems Review Software Review 248

Crunchbase News

SEPTEMBER 3, 2024

In busier years for tech IPOs, the week after Labor Day is a brisk period for roadshows by companies looking to make an autumn market debut. None of the hot venture-backed tech companies seen as likely IPO prospects filed to go public in August. A number of biotechs also carried out IPOs.

Marketing 119

Marketing Technical Review Biotech Software Review 119

Crunchbase News

JUNE 14, 2024

AI, biotech, space tech and cybersecurity also saw good-sized raises. Then, late last year, Cruise suspended its self-driving taxi program across the country after losing its permit to operate in San Francisco due to an incident with a pedestrian. Alzheon , $100M, biotech: Alzheon was the next biotech to raise big this week.

Biotech 129

Biotech Technical Review Artificial Intelligence Artificial Inteligence 129

N2Growth Blog

DECEMBER 12, 2024

At N2Growth, we approach the healthcare leadership market with a nuanced lens, drawing on decades of industry experience to ensure that leaders possess the necessary technical expertise and the resilience, strategic insight, and emotional intelligence essential for inspiring teams and shaping the future of patient care.

Healthcare 78

Healthcare Technical Review Leadership Sustainability 78

TechCrunch

DECEMBER 17, 2022

OK, with that, here’s what I think will happen next year: the return to in-person, five-day work weeks for tech workers. Then, this year, the Great Resignation became the Great Reset, as employers fired large percentages of their staff due to changing macroeconomic conditions. The impact of hype with Clubhouse’s Paul Davison.

Technical Review 246

Technical Review Open Source ChatGPT Biotech 246

TechCrunch

SEPTEMBER 16, 2021

Sorcero announced Thursday a $10 million Series A round of funding to continue scaling its medical and technical language intelligence platform. and Cambridge, Massachusetts, sees increased demand for its advanced analytics from life sciences and technical companies.

Technical Review 222

Technical Review Pharmaceuticals Healthcare Policies 222

TechCrunch

MARCH 23, 2021

Indeed, two of the best funded companies in the lab-grown meat market hail from The Netherlands, where Mosa Meat is being challenged by a newer upstart, Meatable , which just announced $47 million in new financing. Meatable has a long road ahead of it, because, as Gates acknowledged in his interview with MIT Technology Review (ed.

Technical Review 208

Technical Review Biotech Pharmaceuticals Software Review 208

TechCrunch

APRIL 27, 2022

He puts his tally for the number of applications he’s reviewed in the “tens of thousands.” What I’m looking for is technical excellence on the team,” Caldwell said. “I like to see some kind of founder/market fit for what the idea is,” he clarified. They tend to get ripped off.

Technical Review 188

Technical Review How To Biotech Software Review 188

TechCrunch

FEBRUARY 22, 2022

The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path forwards. and wider European markets. the discovery and cultivation of purpose-built microbes).

Hardware 216

Hardware Biotech Technical Review Systems Review 216

TechCrunch

APRIL 11, 2022

Its approach is also drastically different from most fertility service providers — it has savvy, intelligent marketing; a tech-enabled and fully virtual care facility; a focus on compassion; and ample customer education to help patients feel involved and understood. The company today has 12 outlets in 10 cities in the U.S.

Industry 197

Industry Biotech Healthcare Insurance 197

TechCrunch

OCTOBER 8, 2021

. “And these superhero cells are defined by a lot of activity coming from small subsets of cells you would normally miss with existing technologies today.” ” Mackay says there are about 150 IsoPlexis units on the market as of the first half of this year. Though the company pulled in $7.5 in 2020, it lost about $13.6

Company 206

Company Marketing Data Study 206

CIO

APRIL 17, 2024

Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on.

Software Review 194

Software Review Enterprise Generative AI Artificial Inteligence 194

Crunchbase News

OCTOBER 4, 2024

While the IPO market wasn’t especially active, we did see a handful of public offerings, predominantly in the biotech sector. billion went to late-stage and technology growth deals in Q3 of 2024. Below, we chart both round counts and total investment for late-stage and technology growth deals over the past five quarters.

Biotech 129

Biotech Technical Review Artificial Intelligence Artificial Inteligence 129

TechCrunch

FEBRUARY 2, 2022

Synthetic biology, as it’s called when microbes are tuned to a specific purpose, is increasingly viable as the biotech infrastructure supporting it advances. In Zero Acre’s case, they’ve tried to make it easy on themselves to get to market. “Little things can have a big effect.

Biotech 243

Biotech Technical Review Research Energy 243

TechCrunch

APRIL 21, 2021

There are any number of seed rounds that cross our desks every day, a never-ending march of enterprise software, consumer apps, games, hardware, biotech and sometimes even a space startup. How’s that for product-market fit. Let’s hope. Critically, Affect is not opposed to medically assisted recovery, which matters.

Biotech 187

Biotech Software Review Technical Review Artificial Inteligence 187

Crunchbase News

JULY 9, 2024

And there are signs that larger M&A deals increased in Q2, providing much-needed liquidity to venture capital markets. While this past quarter was amongst the highest for funding since Q1 2023, it is not necessarily a signal of a venture market comeback. Healthcare and biotech was the second-largest sector, raising $17 billion.

Biotech 140

Biotech Report Software Review Technical Review 140

Crunchbase News

OCTOBER 24, 2024

Of course, as the above chart shows, the numbers are still way off from the aberration years of 2021 and 2022 — when the venture market exploded to never-seen-before heights — but nevertheless show investors’ growing desire to pump large sums of money into companies they believe in. Where is the money going?

Biotech 129

Biotech Technical Review Fintech Healthcare 129

TechCrunch

AUGUST 5, 2021

While Amsterdam garners the lion’s share of attention in the Netherlands tech ecosystem, the not-so-far-away region around Utrecht has its fair share of tech startups and investors, as is evidenced by our latest survey of locals, below. Jasper Voorendonk , marketer/founder, AgnostiPay. Utrecht is a bit lagging.”

Weak Development Team 203

Weak Development Team Technical Review Sustainability Biotech 203

TechCrunch

FEBRUARY 9, 2022

Once samples are scanned in the lab, they could be reviewed by hematologists working from anywhere. For instance, some papers argue, the manual review of samples doesn’t often add much to doctors’ diagnostic dataset. You can zoom around in one of the images here. Image Credits: Scopio.

Technical Review 223

Technical Review Systems Review Software Review Testing 223